Skip to main content
CYPH
NASDAQ Life Sciences

Cypherpunk Technologies Regains Nasdaq Compliance, Resolving Minimum Bid Price Deficiency

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.23
Mkt Cap
$127.757M
52W Low
$0.232
52W High
$3.7
52W Position info
429% above low
Off High info
67% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CYPH has more than doubled off its 52-week low of $0.232.

Summary

Cypherpunk Technologies Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement, effectively closing the previously reported delisting matter.


Key Events · Corporate Governance and Compliance · CYPH

  • Nasdaq Compliance Regained

    On May 21, 2026, the company received a letter from Nasdaq confirming it had regained compliance with Listing Rule 5550(a)(2) regarding the minimum bid price.

  • Delisting Threat Resolved

    The matter concerning the previously reported Nasdaq deficiency notice, issued on March 4, 2026, for failing to meet the $1.00 minimum bid price, is now closed.


Analysis · CYPH · Life Sciences

This filing is highly important as it resolves a significant delisting threat that Cypherpunk Technologies Inc. faced due to its common stock trading below the $1.00 minimum bid price. The previous deficiency notice was a major concern, and regaining compliance removes a substantial overhang and compliance risk, which is critical for the company's continued listing on Nasdaq.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CYPH was trading at $1.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $127.8M. The 52-week trading range was $0.23 to $3.70. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CYPH - Latest Insights

CYPH
Aug 19, 2026, 6:55 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $3.36 info
Change: +$2.29 (+213%) info
Market Cap: $358.855M info
CYPH
Aug 19, 2026, 6:54 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $3.36 info
Change: +$2.29 (+213%) info
Market Cap: $358.855M info
CYPH
Aug 18, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7269
Real-time Price: $3.36 info
Change: +$2.63 (+362%) info
Market Cap: $358.855M info
CYPH
Aug 12, 2026, 7:16 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.710
Real-time Price: $3.36 info
Change: +$2.65 (+373%) info
Market Cap: $358.855M info
CYPH
Aug 12, 2026, 7:14 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.710
Real-time Price: $3.36 info
Change: +$2.65 (+373%) info
Market Cap: $358.855M info